Your browser doesn't support javascript.
loading
Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.
Nejabati, H R; Mota, A; Farzadi, L; Ghojazadeh, M; Fattahi, A; Hamdi, K; Nouri, M.
Afiliação
  • Nejabati HR; Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mota A; Department of Clinical Biochemistry, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Farzadi L; Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ghojazadeh M; Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Fattahi A; Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hamdi K; Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. hamdik@tbzmed.ac.ir.
  • Nouri M; Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. nourimd@yahoo.com.
J Endocrinol Invest ; 40(2): 207-215, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27664102
ABSTRACT

PURPOSE:

Considering potential roles of soluble receptor for advanced glycation end products (sRAGE) and placental growth factor (PlGF) in ovarian function and embryo implantation, in the present study we have evaluated the association of these factors and also PlGF/sFlt-1 ratio with the ovarian response and implantation rate by dividing patients according to the OSI.

METHODS:

In a cross-sectional study, 90 infertile women who were undergoing ICSI cycle using long protocol were recruited. The patients were divided according to ovarian sensitivity index (OSI). ICSI cycle outcomes were evaluated for each patient and PlGF, sFlt-1 and sRAGE levels of follicular fluid were assayed using commercial ELISA kits.

RESULTS:

Follicular fluid (FF) sRAGE levels and PlGF/sFlt-1 ratio were statistically greater in high-responder women than other responders (p < 0.05). Positive correlations were obtained between sRAGE level with the number of oocytes, follicles and OSI level. sRAGE levels with cutoff value of 4.83 (ng/ml) for evaluating the pregnancy outcome showed 81.8 % sensitivity and 60.7 % specificity. Furthermore, there were positive associations between PlGF/sFlt-1 ratio with the number of oocytes, embryos and OSI level.

CONCLUSION:

In conclusion, the results of current study supported that good ovarian response is independent of pregnancy outcome. Our results showed that FF levels of sRAGE and PlGF/sFlt-1 ratio could be used as markers for determining the high-responder women. Also, FF sRAGE levels could be a good predictor for ART outcome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ovário / Fertilização in vitro / Líquido Folicular / Produtos Finais de Glicação Avançada / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Receptor para Produtos Finais de Glicação Avançada / Fator de Crescimento Placentário / Infertilidade Feminina Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Pregnancy Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ovário / Fertilização in vitro / Líquido Folicular / Produtos Finais de Glicação Avançada / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Receptor para Produtos Finais de Glicação Avançada / Fator de Crescimento Placentário / Infertilidade Feminina Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Pregnancy Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã